Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLGW) Amortizatization of Intangibles (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $1.2 million as the latest value for Q4 2017.

  • Quarterly Amortizatization of Intangibles fell 13.85% to $1.2 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $981659.0 through Dec 2017, down 19.65% year-over-year, with the annual reading at $340735.0 for FY2018, 89.76% down from the prior year.
  • Amortizatization of Intangibles for Q4 2017 was $1.2 million at Bone Biologics, up from $151680.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $1.4 million in Q4 2016, with the low at -$859521.0 in Q2 2017.